Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study.

Journal: Journal of hepatocellular carcinoma
Published Date:

Abstract

BACKGROUND: This study was conducted to assess the efficacy and safety of magnetic resonance (MR)-guided hypofractionated radiotherapy in patients with unresectable hepatocellular carcinoma (HCC). Machine learning-based radiomics was utilized to predict responses in these patients.

Authors

  • Ke Su
    Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Xin Liu
    Peking University Institute of Advanced Agricultural Sciences, Shandong Laboratory of Advanced Agricultural Sciences, Weifang, Shandong, China.
  • Yue-Can Zeng
    Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570311, People's Republic of China.
  • Junnv Xu
    Department of Medical Oncology, The Second Affiliated Hospital, Hainan Medical University, Haikou, Hainan Province, 570311, People's Republic of China.
  • Han Li
  • Heran Wang
    Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People's Republic of China.
  • Shanshan Du
    Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, 350122, Fujian Province, China.
  • Huadong Wang
    School of Computer Science and Technology, Anhui University, China.
  • Jinbo Yue
    Department of Abdominal Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, People's Republic of China.
  • Yong Yin
    Department of Radiation Oncology, Shandong Cancer Hospital, Jinan, Shandong, 250117, China.
  • Zhenjiang Li
    Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China; Shandong Medical Imaging and Radiotherapy Engineering Center (SMIREC), Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Keywords

No keywords available for this article.